Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 54 announcements

Share price: ₹1,783.00
Market cap: ₹4,27,801 Cr
Revenue (annual): ₹58,462 Cr
Net profit (annual): ₹11,479 Cr
P/E (TTM): 35.4×Sector 47.4×
Promoter holding: 54.48%+0.00% QoQ
FII holding: 14.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Promoter Reclassification 2 Merger & Restructuring 2 Legal & Regulatory 2 Credit Rating 2 Business Update 2 Annual General Meeting 2 Regulatory Approval 1 Other Announcement 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

26 Sep 2026 22:17 IST BSE

Promoter Reclassification

Sun Pharmaceutical Industries Promoter Reclassification

Sun Pharmaceutical has received shareholder approval to reclassify specific persons from the 'Promoter Group' to the 'Public' category, in compliance with SEBI Listing Regulations.

Read the filing ↗

6 Aug 2026 20:34 IST NSE

Promoter Reclassification

Sun Pharmaceutical Industries Promoter Reclassification

Sun Pharmaceutical Industries Ltd received no-objection letters from the NSE and BSE to reclassify certain members from the promoter group to the public category.

Read the filing ↗